Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
Rhea-AI Summary
Resmed (NYSE: RMD) will report third quarter fiscal 2026 results on Thursday, April 30, 2026 after the NYSE close and will host a management webcast at 1:30 p.m. PT / 4:30 p.m. ET.
The live webcast is available at https://investor.resmed.com, with replay accessible about two hours after the presentation; phone replay runs April 30–May 14, 2026.
Positive
- None.
Negative
- None.
News Market Reaction – RMD
In the Apr 2 session, RMD gained 0.56%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 08 | Earnings date notice | Neutral | +0.6% | Scheduled Q2 FY2026 earnings release and webcast access details. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings date scheduling produced a small positive move, suggesting these announcements have historically been low-volatility, informational events.
Over the past several months, ResMed has combined operational growth with consistent investor communications. Q2 FY2026 earnings showed revenue of $1.423B and strong margins, while regulatory filings highlighted solid cash and equity positions. The prior earnings date announcement on Jan 8, 2026 saw a modest 0.62% move. Today’s Q3 FY2026 earnings date continues this pattern of regular guidance on upcoming financial disclosures and webcast access details for shareholders.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2026 on Thursday, April 30, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
| • | Location: | https://investor.resmed.com |
| • | Date: | 1:30 p.m. PT / 4:30 p.m. ET |
| • | Time: | London, Thursday, April 30, 2026, 9:30 p.m. BST |
| • | International: | Sydney, Friday, May 1, 2026, 6:30 a.m. AEST |
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from April 30, 2026, until May 14, 2026, at:
- U.S.: +1 877.660.6853
- International: +1 201.612.7415
- Conference ID: 13759381
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For investors | For media |
| +1 858.221.3304 | +1 619.510.1281 |
| investorrelations@Resmed.com | news@Resmed.com |
